General Overview
Insulin Glargine is a basal insulin that provides a relatively flat, constant concentration-time profile over 24 hours with no pronounced peak, mimicking normal baseline insulin secretion.
Medicine Information
Insulin Glargine
Insulin Glargine
Prescription required
Long-Acting Insulin / Antidiabetic
Medicine Safety Disclaimer
This information is for educational purposes only and should not be used for self-diagnosis or self-treatment. Do not start, stop, or change any medicine without consulting a qualified doctor or pharmacist. In case of overdose, severe allergic reaction, breathing difficulty, swelling of the face/lips, unconsciousness, or severe side effects, seek emergency medical help immediately.
Composition
Insulin Glargine (rDNA origin) IP
Strength
100 IU/ml
Medicine Type
Injection (Subcutaneous Cartridge/Pen)
Brand Names
Lantus
Basalog
Glaritus
Reported Uses
Used to treat diabetes mellitus in adults and pediatric patients.
General Characteristics
Once-daily dosing, low risk of nocturnal hypoglycemia (low sugar at night) compared to NPH insulin.
General Mechanism of Action
Binds to insulin receptors, facilitating cellular glucose uptake into muscle and fat cells, and inhibiting hepatic glucose production.
Storage Guidelines
Store unopened vials/pens in a refrigerator (2°C - 8°C). Do not freeze. Opened pens can be kept at room temperature below 30°C for up to 28 days.
General Educational Notes
Always carry fast-acting glucose tablets or candies with you in case of sudden symptoms of low blood sugar.
Frequently Asked Questions
Can I mix Insulin Glargine with other insulins in the same syringe?
No. Insulin Glargine is acidic (pH 4) and precipitates if mixed with other neutral pH insulins, destroying its long-acting profile. Always inject it separately.
How can I identify hypoglycemia (low blood sugar)?
Symptoms include sweating, shaking, rapid heartbeat, anxiety, confusion, dizziness, and headache. If you feel these, eat or drink 15 grams of fast-acting sugar immediately.